The activation of RIPK1 has also been implicated in mediating inflammatory responses in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and Alzheimer’s disease. This evidence concerns the gene RIPK1 and Alzheimer disease.